• Community News
  • Medical and Scientific News
  • Features
Canadian Hemophilia Society
  • Français
chsLogo
  • Community News
  • Medical and Scientific News
  • Features
Home / Community News / WFH Advisory: availability of desmopressin

WFH Advisory: availability of desmopressin

CHS/SCH | 06/10/2020

WFH Advisory: availability of desmopressin pending re-start of intranasal desmopressin manufacture 

  • KEYWORDS

    ADVOCACY ageing A GLOBAL PERSPECTIVE AIDS CARRIERS CHS chapters Community COMPENSATION COVID-19 EMICIZUMAB GENE THERAPY HALF-LIFE FACTOR CONCENTRATES HEMLIBRA HEMOPHILIA A AND B HEPATITIS C HIV ICHIP INHIBITORS MYCBDR NURSING PHYSIOTHERAPY Platelet function disorders PROBE PROPHYLAXIS RARE BLEEDING DISORDERS RESEARCH SOCIAL WORK Tainted blood tragedy THE BLOOD FACTOR THE FEMALE FACTOR THERAPIES THE SAGE PAGE TWINNING VON WILLEBRAND DISEASE

Copyright © 2020 - Canadian Hemophilia Society. All rights reserved.

  • ARCHIVED HEMOPHILIA TODAY
  • ABOUT US